Standout Papers

Targeting KRAS: from metabolic regulation to cancer treatment 2025 202615
  1. Targeting KRAS: from metabolic regulation to cancer treatment (2025)
    Yanyan Shi, Huiling Zheng et al. Molecular Cancer

Immediate Impact

50 standout
Sub-graph 1 of 24

Citing Papers

Polysaccharides with antioxidant activity: Extraction, beneficial roles, biological mechanisms, structure-function relationships, and future perspectives: A review
2025 Standout
Pancreatic cancer
2025 Standout
2 intermediate papers

Works of Baoshan Cao being referenced

A phase I/II study of first-in-human trial of JAB-21822 (KRAS G12C inhibitor) in advanced solid tumors.
2022
The potential roles of Nrf2/Keap1 signaling in anticancer drug interactions
2021

Author Peers

Author Last Decade Papers Cites
Baoshan Cao 213 132 186 64 463
Michele Bartoletti 253 139 121 52 524
Hsin‐Lun Lee 182 138 123 48 491
Joel A. Lefferts 157 86 218 58 510
Marina Sekacheva 162 145 204 57 494
Geng Xu 142 84 171 46 558
Daiki Taniyama 257 102 264 46 500
Xiaoyan Lin 197 93 205 34 484
Yang Peng 199 118 216 43 455
Karel Cwiertka 242 120 113 45 425
Daniel J. Smit 268 69 259 38 539

All Works

Loading papers...

Rankless by CCL
2026